ESR1 and metabolic syndrome: The ESR1 rs2234693 and rs9340799 polymorphisms have been reported as interfering with the action of the estrogen receptor [14–16], leading to the development of risk factors for cardiovascular disease, such as dyslipidemia, insulin resistance, hypertension, central obesity and type 2 diabetes [1,2,18–21].